IGC Pharma (IGC) Other Non-Current Liabilities (2011 - 2025)
IGC Pharma (IGC) reported Other Non-Current Liabilities of $16000.0 for Q1 2025, down 20.0% year-over-year from $20000.0 in Q1 2024, and little changed quarter-over-quarter from $16000.0 in Q4 2024.
IGC Pharma (IGC) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
IGC Pharma (IGC) has 14 years of Other Non-Current Liabilities data on file, last reported at $16000.0 in Q1 2025.
- Other Non-Current Liabilities for Q1 2025 came in at $16000.0, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2025 was $16000.0 (down 20.0% YoY), and the FY2025 annual result was $16000.0, down 20.0% from the prior year.
- Other Non-Current Liabilities steadied at $16000.0 in Q1 2025 per IGC's latest filing, from $16000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $21000.0 in Q1 2023 and troughed at $15000.0 in Q1 2021.
- A 5-year average of $17058.8 and a median of $16000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities soared 31.25% in 2023, then dropped 20.0% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $15000.0 in 2021, then changed by 0.0% to $15000.0 in 2022, then increased by 13.33% to $17000.0 in 2023, then decreased by 5.88% to $16000.0 in 2024, then changed by 0.0% to $16000.0 in 2025.
- Business Quant data shows IGC's Other Non-Current Liabilities at $16000.0 in Q1 2025, $16000.0 in Q4 2024, and $20000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Dec 31, 2020 | 17,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Jun 30, 2020 | 16,000.00 |